49.1 Acute Fever, Sepsis Screening & FUO in Primary Care

Thermoregulation: Fever vs. Hyperthermia

Body temperature in humans is precisely regulated by the preoptic area of the anterior hypothalamus, which maintains a thermal equilibrium or "set-point" between 36.5°C and 37.5°C (97.7°F to 99.5°F). Pathologic elevations in body core temperature fall into two distinct pathophysiologic entities: pyrogenic fever and hyperthermia.

Molecular Pathophysiology of Fever

Fever represents a regulated elevation of the hypothalamic thermostatic set-point initiated by pyrogenic stimuli:

1. Exogenous Pyrogens: Microbial products, notably bacterial lipopolysaccharide (LPS/endotoxin from Gram-negative bacteria) or lipoteichoic acid and peptidoglycans from Gram-positive organisms, stimulate host immune cells via Toll-like receptors (TLRs).
2. Endogenous Pyrogenic Cytokines: Activated monocytes, tissue macrophages, and endothelial cells synthesize and release endogenous pyrogens, primarily interleukin-1 (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6).
3. Hypothalamic Transduction: These circulating cytokines travel to the fenestrated capillary network of the organum vasculosum of the lamina terminalis (OVLT), a circumventricular organ bordering the anterior hypothalamus that lacks a tight blood-brain barrier. Cytokines bind to endothelial receptors, inducing the expression of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E synthase-1.
4. Prostaglandin E2 (PGE2) Synthesis & Set-Point Shift: Endothelial cells release PGE2, which diffuses across into adjacent hypothalamic glial and neural tissue, binding to EP3 prostanoid receptors on thermoregulatory neurons in the preoptic area. This receptor activation suppresses warm-sensitive neurons and stimulates cold-sensitive neurons, effectively elevating the hypothalamic thermostatic set-point to a higher level (e.g., 38.5°C to 40.0°C).
5. Thermoregulatory Efferent Responses: Perceiving the current body temperature as abnormally cold relative to the new elevated set-point, the hypothalamus coordinates autonomic and behavioral heat conservation mechanisms: peripheral vasoconstriction (pale, cool extremities), involuntary rhythmic muscular contractions (shivering / rigors), and behavioral seeking of warmth (curling up, bundling in blankets). Once the elevated set-point is reached, shivering ceases, and core temperature remains stabilized at the higher level.
6. Defervescence: When pyrogenic cytokines subside or antipyretics are administered, the set-point resets downward to normal (37.0°C). The hypothalamus initiates active heat dissipation mechanisms: cutaneous vasodilation (flushing) and profuse diaphoresis ("the fever breaks").

                    MOLECULAR CASCADE OF PYROGENIC FEVER

   Exogenous Pyrogens (Bacterial LPS, Viral Antigens, Peptidoglycan)
                               │
                               ▼
   Monocytes / Macrophages Activation ──► IL-1β, TNF-α, IL-6 Release
                               │
                               ▼
   Circulation to Organum Vasculosum Laminae Terminalis (OVLT)
                               │
                               ▼
   Endothelial COX-2 Induction ──► Prostaglandin E2 (PGE2) Synthesis
                               │
                               ▼
   EP3 Receptor Activation in Preoptic Anterior Hypothalamus
                               │
                               ▼
   UPWARD RESETTING OF THERMOSTATIC SET-POINT (e.g., 37°C ──► 39°C)
       ├── Heat Conservation: Peripheral Vasoconstriction (chills)
       └── Heat Production: Involuntary Shivering / Rigors

Hyperthermia: Failure of Thermoregulation

In contrast to fever, hyperthermia is characterized by an unchanged, normal hypothalamic set-point accompanied by an uncontrolled, life-threatening rise in core body temperature due to either excessive endogenous heat production, overwhelming environmental heat absorption, or impaired peripheral heat dissipation.

Because the hypothalamic set-point is normal, hypothalamic efferent mechanisms are actively striving to cool the body (maximal cutaneous vasodilation, intense sweating), but physiological mechanisms are overwhelmed or exhausted.

[!CAUTION] CRITICAL PHARMACOLOGIC PEARL: ANTIPYRETICS IN HYPERTHERMIA Antipyretic agents (acetaminophen, ibuprofen, aspirin) act exclusively by inhibiting hypothalamic COX-2 and blocking PGE2 synthesis to lower an elevated thermostatic set-point.

In hyperthermia, because the hypothalamic set-point is already normal, antipyretics are completely ineffective and potentially harmful (increasing risks of acetaminophen hepatotoxicity or NSAID-induced acute tubular necrosis in dehydrated, rhabdomyolysis-prone patients). Management requires immediate, active physical cooling (conductive and evaporative cooling) and etiology-specific pharmacotherapy.

Major Clinical Hyperthermia Syndromes

1. Heat Stroke: Core temperature >40.0°C (>104.0°F) associated with profound central nervous system dysfunction (delirium, ataxia, seizures, coma) and multiorgan failure. Classified as classic (non-exertional) heat stroke (elderly, frail patients with impaired mobility in heatwaves; anhidrosis often present) or exertional heat stroke (young athletes, military recruits, outdoor laborers performing vigorous exercise in warm/humid environments; profuse sweating frequently persists). First-line treatment is immediate ice-water immersion cooling (reducing temperature to <39°C within 30 minutes).
2. Neuroleptic Malignant Syndrome (NMS): Idiosyncratic life-threatening reaction to dopamine D2 receptor antagonists (high-potency typical antipsychotics like haloperidol, fluphenazine; atypical antipsychotics; antiemetics like metoclopramide) or abrupt cessation of dopaminergic agonists (in Parkinson disease). Characterized by the tetrad of severe hyperthermia, generalized "lead-pipe" muscle rigidity, autonomic instability (labile hypertension, tachycardia, tachypnea, diaphoresis), and altered mental status. Laboratory hallmark: marked elevation in serum creatine kinase (CK often >1,000 to >50,000 U/L) and leukocytosis. Treatment: immediately discontinue offending neuroleptic, aggressive ICU supportive care, IV fluids, and pharmacotherapy with dantrolene (ryanodine channel blocker) or bromocriptine (dopamine agonist).
3. Serotonin Syndrome (Toxicity): Acute hyper-serotonergic toxidrome caused by excess serotonergic agonism, classically resulting from drug interactions (e.g., SSRIs/SNRIs combined with MAOIs, tramadol, linezolid, dextromethorphan, triptans, or St. John's wort). Diagnosed via the validated Hunter Serotonin Toxicity Criteria: in the presence of a serotonergic agent, spontaneous clonus; OR inducible clonus with agitation or diaphoresis; OR ocular clonus with agitation or diaphoresis; OR tremor with hyperreflexia; OR hypertonia with temperature >38°C plus ocular or inducible clonus. Key diagnostic differentiators from NMS: hyperreflexia and neuromuscular clonus (predominantly in lower extremities) rather than "lead-pipe" rigidity, rapid onset within hours (vs. days-to-weeks in NMS), and gastrointestinal hypermotility (cramping, hyperactive bowel sounds, diarrhea).
4. Malignant Hyperthermia (MH): Autosomal dominant pharmacogenetic disorder of skeletal muscle excitation-contraction coupling, most commonly involving mutations in the ryanodine receptor 1 (RYR1) gene. Triggered by exposure to potent volatile inhalational anesthetics (halothane, isoflurane, sevoflurane, desflurane) or the depolarizing neuromuscular blocker succinylcholine. Uncontrolled calcium release from the sarcoplasmic reticulum triggers sustained muscle contraction, explosive hypermetabolism, hypercapnia (rising end-tidal CO2 despite hyperventilation is the earliest sign), masseter muscle spasm, rapid hyperthermia (rising 1°C every 5 minutes), rhabdomyolysis, severe metabolic acidosis, and hyperkalemic cardiac arrest. Definitive treatment: immediate cessation of triggering agents, hyperventilation with 100% O2, and rapid IV administration of Dantrolene sodium (2.5 mg/kg IV initial bolus, repeated until hypermetabolism ceases).

                  COMPARISON OF HYPERTHERMIA SYNDROMES

   Syndrome       Etiology / Triggers       Key Neuromuscular Signs       Specific Treatment
   ═════════════════════════════════════════════════════════════════════════════════════════════
   Heat Stroke    Environmental exposure    Ataxia, flaccidity, coma,    Ice water immersion;
                  or intense exertion       seizures; NO rigidity         evaporative cooling

   NMS            Dopamine D2 antagonists   "Lead-pipe" severe rigidity,  Dantrolene or
                  (antipsychotics)          bradykinesia, hyporeflexia    Bromocriptine

   Serotonin      Serotonergic drug excess  Hyperreflexia, clonus,       Cyproheptadine,
   Syndrome       (SSRIs, MAOIs, linezolid) ocular clonus, tremor         Benzodiazepines

   Malignant      Volatile anesthetics      Masseter jaw spasm,          Dantrolene sodium
   Hyperthermia   or Succinylcholine        generalized muscle rigidity   IV (2.5 mg/kg)
   ═════════════════════════════════════════════════════════════════════════════════════════════

---

Sepsis Screening & Early Resuscitation in Primary Care

Sepsis represents one of the leading causes of acute mortality worldwide. In ambulatory, urgent care, and primary care clinic settings, recognizing the early signs of sepsis is critical, as every hour of delayed antimicrobial therapy significantly increases mortality.

Sepsis-3 Consensus Definitions

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) redefined the condition:

• Sepsis: Defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. In hospital and ICU settings, organ dysfunction is formally quantified by an acute change in total Sequential Organ Failure Assessment (SOFA) score of >=2 points attributable to the infection, which reflects an in-hospital mortality risk exceeding 10%.
• Septic Shock: A subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. Clinically defined by persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) >=65 mmHg AND a serum lactate level >2.0 mmol/L (18 mg/dL) despite adequate fluid resuscitation (mortality >40%).

Ambulatory Risk Stratification: qSOFA vs. SIRS Criteria

Because calculating a full SOFA score requires laboratory values (PaO2, platelets, bilirubin, creatinine) unavailable during initial outpatient triage, the Sepsis-3 task force introduced the quick SOFA (qSOFA) as an actionable bedside risk-stratification tool.

                         THE qSOFA SCREENING CRITERIA

   Clinical Parameter              Threshold Value            Points Assigned
   ─────────────────────────────────────────────────────────────────────────────
   Respiratory Rate (RR)           >= 22 breaths per minute          1 point
   Altered Mental Status           Glasgow Coma Scale < 15           1 point
   Systolic Blood Pressure (SBP)   <= 100 mmHg                       1 point
   ─────────────────────────────────────────────────────────────────────────────
   A qSOFA score >= 2 identifies infected patients at high risk of in-hospital
   mortality and ICU admission, warranting immediate transfer to an Emergency Dept.

• Systemic Inflammatory Response Syndrome (SIRS): Historically, sepsis was defined as SIRS plus suspected infection. SIRS requires >=2 of the following 4 criteria:
  1. Core temperature >38.0°C (100.4°F) or <36.0°C (96.8°F);
  2. Heart rate >90 beats/min;
  3. Respiratory rate >20 breaths/min OR PaCO2 <32 mmHg;
  4. White blood cell count >12,000/mcL, <4,000/mcL, OR >10% immature band forms.
• Clinical Utility & Nuance:
  • SIRS is highly sensitive but non-specific; many ambulatory patients with uncomplicated viral infections or non-infectious inflammatory triggers (pancreatitis, trauma, exercise) meet SIRS criteria.
  • qSOFA is less sensitive but highly specific for adverse outcomes and organ dysfunction. An ambulatory patient with suspected infection and a qSOFA score >=2 must NEVER be treated as an outpatient; they require immediate 911 activation and emergency department transfer.

The Surviving Sepsis Campaign "Hour-1 Bundle"

Once sepsis is recognized, the international Surviving Sepsis Campaign guidelines mandate initiation of resuscitation bundle elements within 1 hour of triage:

1. Measure Blood Lactate Level: Elevated lactate (>2.0 mmol/L) reflects anaerobic metabolism and tissue hypoperfusion. A lactate >=4.0 mmol/L indicates severe metabolic stress and tissue dysoxia. Remeasure lactate within 2 to 4 hours to guide resuscitation (targeting lactate clearance).
2. Obtain Blood Cultures Prior to Antibiotics: Draw at least two sets of peripheral blood cultures (aerobic and anaerobic) from distinct venipuncture sites. Do not delay antimicrobial initiation by >45 minutes if blood cultures cannot be rapidly obtained.
3. Administer Broad-Spectrum Intravenous Antimicrobials: Initiate broad-spectrum empiric IV antimicrobials covering Gram-positive and Gram-negative pathogens within 1 hour of recognition.
4. Rapid Intravenous Crystalloid Resuscitation: Administer a minimum of 30 mL/kg of balanced intravenous crystalloids (e.g., Lactated Ringer's or Plasmalyte) within the first 3 hours for patients with hypotension (mean arterial pressure <65 mmHg) OR initial serum lactate >=4.0 mmol/L.
5. Vasopressor Therapy: If the patient remains hypotensive during or immediately following the 30 mL/kg fluid bolus, initiate vasopressors to maintain MAP >=65 mmHg. Norepinephrine is the first-line vasopressor of choice (titrated to MAP >=65 mmHg); vasopressin (0.03 units/min) can be added as a second-line agent.

---

Fever of Unknown Origin (FUO): Diagnostic Strategy

Fever of unknown origin presents one of the most intellectually rigorous diagnostic dilemmas in primary care and internal medicine.

The Classic Definition of FUO

Originally formulated by Petersdorf and Beeson in 1961 and refined by Durack and Street in 1991, classic FUO requires meeting all three of the following criteria:

1. Documented body temperature >38.3°C (>101.0°F) on multiple separate occasions;
2. Fever duration exceeding 3 weeks;
3. Failure to reach a definitive diagnosis despite 1 week of intensive inpatient investigation OR after 3 outpatient clinical visits (or 3 days of focused outpatient testing).

(Note: Durack and Street also classified three additional distinct FUO subtypes: Nosocomial FUO, Neutropenic FUO [ANC <500/mcL], and HIV-associated FUO, each possessing different etiologic spectra and requiring tailored workups).

                  THE FOUR MAJOR ETIOLOGIC CATEGORIES OF FUO

   Etiologic Category       Approximate Frequency    Prototypic Diagnoses
   ═════════════════════════════════════════════════════════════════════════════════════════
   Infections               30% to 40%               Occult intra-abdominal/pelvic abscess,
                                                     infective endocarditis, osteomyelitis,
                                                     extrapulmonary/miliary TB, EBV/CMV

   Neoplasms                20% to 30%               Non-Hodgkin lymphoma, Hodgkin lymphoma,
                                                     leukemia, Renal Cell Carcinoma (RCC),
                                                     atrial myxoma, hepatocellular carcinoma

   Non-Infectious           15% to 20%               Giant Cell Arteritis (GCA) / PMR,
   Inflammatory Disorders                            Adult-Onset Still Disease (AOSD),
   (Connective Tissue/Auto)                          SLE, Polyarteritis nodosa, RA

   Miscellaneous / Other    10% to 15%               Drug fever, subacute thyroiditis (de
                                                     Quervain), DVT/PE, factitious fever
   ═════════════════════════════════════════════════════════════════════════════════════════
   Note: In up to 10% to 20% of modern FUO evaluations, no definitive etiology is found
   despite exhaustive workup; the majority of these undiagnosed patients experience benign
   spontaneous resolution over time.

Infectious Etiologies (30-40%)

• Occult Pyogenic Abscesses: Intra-abdominal (subphrenic, diverticular, appendiceal, hepatic pyogenic abscesses), pelvic (tubo-ovarian), or retroperitoneal/perinephric abscesses. Often insidious in diabetics or elderly patients without localized peritoneal signs.
• Infective Endocarditis (IE): Subacute bacterial endocarditis caused by Streptococcus viridans, Enterococcus faecalis, or indolent HACEK organisms (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella). May present with culture-negative endocarditis (Bartonella, Coxiella burnetii [Q fever], Chlamydia).
• Mycobacterial Infection: Miliary or extrapulmonary tuberculosis (skeletal Pott disease, renal TB, tuberculous peritonitis). Tuberculin skin tests and interferon-gamma release assays (IGRAs) can be falsely negative in disseminated or anergic disease.
• Osteomyelitis: Particularly vertebral osteomyelitis or infected spinal hardware, presenting with low back pain and elevated inflammatory markers.
• Systemic Viral Infections: Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and acute human immunodeficiency virus (HIV) seroconversion syndrome.

Neoplastic Etiologies (20-30%)

• Lymphomas: Both Hodgkin lymphoma (classically displaying Pel-Ebstein fevers—cyclical high fevers for 1-2 weeks alternating with afebrile periods) and Non-Hodgkin lymphoma. Characterized by "B symptoms" (fevers, drenching night sweats, involuntary weight loss >10% over 6 months).
• Renal Cell Carcinoma (RCC): Paraneoplastic fever is observed in up to 20% of RCC cases, mediated by tumor production of IL-6. The classic triad (hematuria, flank pain, palpable mass) is present in <10%; paraneoplastic signs include erythrocytosis, hypercalcemia, and hepatic dysfunction without metastases (Stauffer syndrome).
• Leukemias & Myelodysplastic Syndromes: Acute and chronic leukemias.
• Atrial Myxoma: Benign cardiac neoplasm producing IL-6, causing fevers, weight loss, elevated ESR, embolic phenomena, and an auscultatory "tumor plop" mimicking mitral stenosis.

Non-Infectious Inflammatory Disorders (15-20%)

• Giant Cell Arteritis (GCA) / Polymyalgia Rheumatica (PMR):
  • The most frequent rheumatologic cause of FUO in adults aged >=50 years.
  • Clinical features: Unilateral throbbing temporal headache, scalp tenderness (pain when combing hair), jaw claudication (ischemic fatigue of masseter muscles while chewing, highly specific), polymyalgia symptoms (bilateral morning shoulder and hip girdle aching), and amaurosis fugax or sudden visual loss.
  • Laboratory findings: ESR markedly elevated (almost universally >50 mm/h, frequently >100 mm/h) and elevated CRP.
  • Immediate mandate: If GCA is suspected, initiate high-dose systemic corticosteroid therapy immediately (prednisone 40-60 mg daily) to prevent irreversible ischemic optic neuropathy and bilateral permanent blindness. Do NOT wait for a temporal artery biopsy.
• Adult-Onset Still Disease (AOSD):
  • Severe systemic inflammatory disorder characterized by the Yamaguchi criteria:
    1. Quotidian Spiking Fevers: Daily high spiking fevers (typically peaking in late afternoon or evening >39°C [102.2°F]) that return to baseline between spikes.
    2. Evanescent Rash: An evanescent, non-pruritic, salmon-pink maculopapular rash that characteristically erupts on the trunk and proximal extremities during the fever spike and rapidly fades when temperature normalizes.
    3. Arthralgias / Arthritis: Transient or persistent inflammatory polyarthritis.
    4. Leukocytosis: Marked neutrophilic leukocytosis (WBC >=10,000/mcL with >=80% neutrophils).
    5. Extreme Hyperferritinemia: Serum ferritin concentrations are dramatically elevated, frequently exceeding 3,000 to >10,000 ng/mL (normal <300 ng/mL), with a glycosylated ferritin fraction <20%.
    6. Seronegativity: Antinuclear antibodies (ANA) and Rheumatoid Factor (RF) are characteristically negative.

Miscellaneous Etiologies (10-15%)

• Drug Fever:
  • An underdiagnosed hypersensitivity reaction occurring days to months after drug initiation. Offending agents commonly include beta-lactam antibiotics, sulfonamides, anticonvulsants (phenytoin, carbamazepine), antiarrhythmics (procainamide, quinidine), heparin, and allopurinol.
  • Clinical clues: Patient often appears paradoxically comfortable despite high fevers; relative bradycardia (Faget sign) may be present; mild peripheral eosinophilia occurs in only 20-30%.
  • Definitive diagnosis & cure: Rapid defervescence occurs within 48 to 72 hours of discontinuing the offending drug.
• Subacute Granulomatous Thyroiditis (de Quervain): Post-viral inflammatory thyroiditis presenting with anterior neck pain, exquisitely tender goiter, elevated ESR, and suppressed TSH with low radioactive iodine uptake.
• Venous Thromboembolism: Occult deep vein thrombosis (DVT) or recurrent micro-pulmonary emboli (PE) inducing low-grade fevers.
• Factitious Fever: Feigned or self-induced fevers (pathomimicry). Red flags: Absence of normal diurnal body temperature variation; lack of shivering or diaphoresis during abrupt temperature changes; discrepancy between oral temperature and freshly voided urine temperature (urine temperature normally matches or slightly exceeds core oral temperature); normal resting heart rate despite recorded oral temperature >39.5°C; multiple hospital presentations across different health systems.